Cargando…
Symptom and Performance Validity Assessment in European Countries: an Update
In 2013, a special issue of the Spanish journal Clínica y Salud published a review on symptom and performance validity assessment in European countries (Merten et al. in Clínica y Salud, 24(3), 129–138, 2013). At that time, developments were judged to be in their infancy in many countries, with majo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612718/ https://www.ncbi.nlm.nih.gov/pubmed/34849185 http://dx.doi.org/10.1007/s12207-021-09436-8 |
_version_ | 1784603500956614656 |
---|---|
author | Merten, Thomas Dandachi-FitzGerald, Brechje Hall, Vicki Bodner, Thomas Giromini, Luciano Lehrner, Johann González-Ordi, Héctor Santamaría, Pablo Schmand, Ben Di Stefano, Giuseppe |
author_facet | Merten, Thomas Dandachi-FitzGerald, Brechje Hall, Vicki Bodner, Thomas Giromini, Luciano Lehrner, Johann González-Ordi, Héctor Santamaría, Pablo Schmand, Ben Di Stefano, Giuseppe |
author_sort | Merten, Thomas |
collection | PubMed |
description | In 2013, a special issue of the Spanish journal Clínica y Salud published a review on symptom and performance validity assessment in European countries (Merten et al. in Clínica y Salud, 24(3), 129–138, 2013). At that time, developments were judged to be in their infancy in many countries, with major publication activities stemming from only four countries: Spain, The Netherlands, Great Britain, and Germany. As an introduction to a special issue of Psychological Injury and Law, this is an updated report of developments during the last 10 years. In that period of time, research activities have reached a level where it is difficult to follow all developments; some validity measures were newly developed, others were adapted for European languages, and validity assessment has found a much stronger place in real-world evaluation contexts. Next to an update from the four nations mentioned above, reports are now given from Austria, Italy, and Switzerland, too. |
format | Online Article Text |
id | pubmed-8612718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-86127182021-11-26 Symptom and Performance Validity Assessment in European Countries: an Update Merten, Thomas Dandachi-FitzGerald, Brechje Hall, Vicki Bodner, Thomas Giromini, Luciano Lehrner, Johann González-Ordi, Héctor Santamaría, Pablo Schmand, Ben Di Stefano, Giuseppe Psychol Inj Law Article In 2013, a special issue of the Spanish journal Clínica y Salud published a review on symptom and performance validity assessment in European countries (Merten et al. in Clínica y Salud, 24(3), 129–138, 2013). At that time, developments were judged to be in their infancy in many countries, with major publication activities stemming from only four countries: Spain, The Netherlands, Great Britain, and Germany. As an introduction to a special issue of Psychological Injury and Law, this is an updated report of developments during the last 10 years. In that period of time, research activities have reached a level where it is difficult to follow all developments; some validity measures were newly developed, others were adapted for European languages, and validity assessment has found a much stronger place in real-world evaluation contexts. Next to an update from the four nations mentioned above, reports are now given from Austria, Italy, and Switzerland, too. Springer US 2021-11-24 2022 /pmc/articles/PMC8612718/ /pubmed/34849185 http://dx.doi.org/10.1007/s12207-021-09436-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Merten, Thomas Dandachi-FitzGerald, Brechje Hall, Vicki Bodner, Thomas Giromini, Luciano Lehrner, Johann González-Ordi, Héctor Santamaría, Pablo Schmand, Ben Di Stefano, Giuseppe Symptom and Performance Validity Assessment in European Countries: an Update |
title | Symptom and Performance Validity Assessment in European Countries: an Update |
title_full | Symptom and Performance Validity Assessment in European Countries: an Update |
title_fullStr | Symptom and Performance Validity Assessment in European Countries: an Update |
title_full_unstemmed | Symptom and Performance Validity Assessment in European Countries: an Update |
title_short | Symptom and Performance Validity Assessment in European Countries: an Update |
title_sort | symptom and performance validity assessment in european countries: an update |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612718/ https://www.ncbi.nlm.nih.gov/pubmed/34849185 http://dx.doi.org/10.1007/s12207-021-09436-8 |
work_keys_str_mv | AT mertenthomas symptomandperformancevalidityassessmentineuropeancountriesanupdate AT dandachifitzgeraldbrechje symptomandperformancevalidityassessmentineuropeancountriesanupdate AT hallvicki symptomandperformancevalidityassessmentineuropeancountriesanupdate AT bodnerthomas symptomandperformancevalidityassessmentineuropeancountriesanupdate AT girominiluciano symptomandperformancevalidityassessmentineuropeancountriesanupdate AT lehrnerjohann symptomandperformancevalidityassessmentineuropeancountriesanupdate AT gonzalezordihector symptomandperformancevalidityassessmentineuropeancountriesanupdate AT santamariapablo symptomandperformancevalidityassessmentineuropeancountriesanupdate AT schmandben symptomandperformancevalidityassessmentineuropeancountriesanupdate AT distefanogiuseppe symptomandperformancevalidityassessmentineuropeancountriesanupdate |